LKFT NASDAQ
Lakefront Biotherapeutics N.V.
1W: -7.6%
1M: -4.0%
3M: -7.4%
YTD: -5.8%
$26.81
+0.00 (+0.00%)
Weekly Expected Move ±4.6%
$24
$26
$27
$28
$29
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.8B
52W Range25.68-37.78
Volume245,818
Avg Volume197,741
Beta0.12
Dividend—
Analyst Ratings
Company Info
CEOHenry O. Gosebruch
Employees452
SectorHealthcare
IndustryBiotechnology
IPO Date2005-05-05
Websitelakefrontbio.com
SchaliEnhoevedreef 20 T
Mechelen 2800
BE
Mechelen 2800
BE
32 1 534 29 00
About Lakefront Biotherapeutics N.V.
Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.
Latest News
No recent news
Recent Insider Trades
No insider trades found